Deepak Khanna is the current President of the ABPI, having been appointed to the role in April 2012.
Since taking on the UK appointment of Managing Director at MSD in November 2009, Deepak has played an active role in industry-wide affairs, notably as Board Member of the ABPI and Chair of the American Pharmaceutical Group (APG).
In his previous role, Deepak was Senior Vice President and General Manager of Merck/Schering-Plough Pharmaceuticals. He managed all aspects of the US Merck/Schering-Plough Joint Venture and was responsible for the US marketing and sales for the two cardiovascular products jointly marketed by the two companies. After the announcement of plans to merge with Schering-Plough (March 2009), Deepak also led the US integration planning efforts.
Deepak began his career at Merck in 1988 in field sales and progressed to positions of increasing responsibility within the US Human Health Division. In 1996, Deepak joined the Worldwide Human Health Marketing Division working with rheumatology products; he later assumed responsibility for the marketing planning activities to support early stage central nervous system products. Deepak rejoined the US Human Health Division in 2001 and assumed leadership responsibilities of the Migraine Franchise Business Group. In January 2003, he was promoted to Vice President of the Atherosclerosis Franchise Business Group.
Deepak holds dual nationality, both British and American. He lives in London with his young family. He earned a Bachelor's degree in biochemistry and economics from the University of California, Berkeley and an MBA in marketing from Santa Clara University.